AoU Research Priorities Use Cases

In Overactive Bladder does pharmacogenomics influence individual response to antimuscarinic and beta-agonist bladder medication?

Overactive bladder is highly prevalent with significant impact on quality of life. Medications are utilized despite variable efficacy, high side effect burden, and poor persistence on therapy. This study will identify an overactive bladder cohort who have been prescribed antimuscarinic or beta-agonist medication to relieve symptoms. We hypothesize relief of symptoms will be based on the individuals pharmacogenomics. Personalized prescribing will permit better utilization of health care resources

Keywords

Voting

28 votes
Ideate
Idea No. 267